Concord Biotech (BOM:543960) Total Stockholders Equity : ₹15,266 Mil (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Concord Biotech Total Stockholders Equity?

Concord Biotech's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ₹15,266 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Concord Biotech's Book Value per Share for the quarter that ended in Mar. 2024 was ₹145.93. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Concord Biotech's Debt-to-Equity for the quarter that ended in Mar. 2024 was 0.01.

Concord Biotech Total Stockholders Equity Historical Data

The historical data trend for Concord Biotech's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Concord Biotech Total Stockholders Equity Chart

Concord Biotech Annual Data

Trend

Mar20

Mar21

Mar22

Mar23

Mar24

Total Stockholders Equity

7,702.34

9,993.73

11,032.23

12,900.01

15,266.46

Concord Biotech Semi-Annual Data
	Mar20	Mar21	Mar22	Sep22	Mar23	Sep23	Mar24
Total Stockholders Equity	Get a 7-Day Free Trial			11,032.23	-	12,900.01	13,543.09	15,266.46

Concord Biotech (BOM:543960) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Concord Biotech's Book Value per Share for the quarter that ended in Mar. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(15266.455	-	0)	/	104.616
	=	145.93

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Concord Biotech's Debt-to-Equity for the quarter that ended in Mar. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(78.506	+	18.87)	/	15266.455
	=	0.01

Concord Biotech Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Concord Biotech's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Concord Biotech (BOM:543960) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Concord Biotech Ltd (BOM:543960) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

CONCORDBIO:India

Address

Iscon Cross Road, S.G. Highway, 16th floor, B-Wing, Mondeal Heights, Ahmedabad, GJ, IND, 380015

Website

https://www.concordbiotech.com

Concord Biotech Ltd is a Research & development-driven biopharma Company that manufactures Active Pharmaceutical Ingredients (API) through fermentation & semi-synthetic process and finished formulations.

Concord Biotech (BOM:543960) Headlines

No Headlines